MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Prostate
Exelixis, Inc. (NASDAQ: EXEL)*
Finance & Acquisition: Exelixis
Parents
Exelixis, Inc. (NASDAQ: EXEL)*
Children
2010: Exelixis Nabs $60M Upfront, Potentially $505M More, From New Deal With Bristol-Myers (2010)
2011: Exelixis Pockets $156M in Stock Sale, Riding Wave of Prostate Cancer Drug Results
2017: 2 Possible Acquisition Targets For Gilead Sciences - Gilead Sciences, Inc. (NASDAQ:GILD)
2022: Exelixis, Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2025: Exelixis, Inc. 2024 Q4 - Results - Earnings Call Presentation
Exelixis Inc Stock Quote: EXEL Stock News, Quotes, Analysis
Exelixis_crunchbase
Exelixis, Inc. (EXEL) Analyst Research
Revenue: 1.435 billion USD (2021)
Jumps
*Key People: Exelixis
Organization & Developments: Exelixis